bluebird bio

Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

About

bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.

Mission

Bluebird bio's core mission is centered around revolutionizing healthcare by developing and delivering innovative gene therapies to patients with severe genetic diseases and cancer. Their primary goal is to harness the power of cutting-edge science and technology to create life-changing treatments, ultimately improving the lives of those affected by these conditions. By fostering a culture of collaboration and scientific excellence, bluebird bio aims to make a lasting impact on the healthcare landscape and redefine the possibilities for patients and their families.

Employee Benefits

  • Deep commitment to fostering an environment where diversity and inclusion are valued and prioritized
  • Equal opportunity employer
  • Welcoming and diverse environment
  • Consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, veteran status or any other applicable legally protected characteristics

Core Values

  • Patient focus: Bluebird bio puts patients at the center of everything they do, striving to develop innovative gene therapies that can transform lives.
  • Collaboration: Bluebird bio values teamwork and collaboration, recognizing that the best solutions come from diverse perspectives and shared problem-solving.
  • Integrity: Bluebird bio operates with the highest ethical standards, prioritizing transparency, honesty, and accountability in all aspects of their work.
  • Innovation: Bluebird bio is committed to pushing the boundaries of science and technology, constantly exploring new ideas and approaches to gene therapy development.
  • Passion: Bluebird bio's employees are driven by a shared passion for making a difference in the lives of patients, and are dedicated to working tirelessly to achieve this goal.

bluebird bio

Leadership

Chief Business and Legal Officer at bluebird bio

Joseph Vittiglio

Chief Business and Legal Officer
Member of the Board of Directors at bluebird bio

Steven Gillis

Member of the Board of Directors
Member of the Board of Directors at bluebird bio

David Schenkein

Member of the Board of Directors

Open Jobs

No items found.
Location
Somerville, MA
N/A
Company Size
501-1,000
N/A
Revenue Range
$10M to $50M
N/A
Valuation
N/A
Founded
1993-01-01
N/A
Current Status
IPO
N/A
Work Mode
Open Roles
10
Hiring Now
Hiring now

Funding

Total Funding
$
597550000
Funding Rounds
10
Num Investors
1
Work Mode
IPO Status
Public
Funding Stage
IPO
Last Funding Date
2023-01-18
Last Funding Type
Post IPO Equity
Hiring Now
Hiring now
Track & Research bluebird bio for Your Next Interview
Start Tracking for Free

Want Jobs in Your Inbox?

Sign up for the Teal newsletter and get career guidance and new jobs weekly!
Thank you! Your submission has been received!
Oops! Please provide a correct email address